Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatment.
Anna Y PalmerAnna WilkinsonCampbell AitkenPaul DietzeGregory J DoreLisa MaherRachel Sacks-DavisMark StooveDavid WilsonMargaret HellardNick ScottPublished in: Journal of gastroenterology and hepatology (2021)
Our updated estimate provides an important baseline for evaluating the impact of hepatitis C elimination efforts and can be used to validate outcomes of future modeling studies.